{
    "organizations": [],
    "uuid": "207e8683cb2c928c27be78e413c7fc69ee72c8a5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-immunovaccine-announces-125-millio/brief-immunovaccine-announces-12-5-million-bought-deal-offering-idUSASB0C2CF",
    "ord_in_thread": 0,
    "title": "BRIEF-Immunovaccine Announces $12.5 Million Bought Deal Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Immunovaccine Inc:\n* IMMUNOVACCINE ANNOUNCES $12.5 MILLION BOUGHT DEAL OFFERING\n* IMMUNOVACCINE INC - ENTERED INTO BOUGHT DEAL FINANCING AGREEMENT TO SELL 6.3 MILLION COMMON SHARES AT A PRICE OF $2.00 PER COMMON SHARE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-25T21:35:00.000+02:00",
    "crawled": "2018-01-26T21:27:55.030+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "immunovaccine",
        "inc",
        "immunovaccine",
        "announces",
        "million",
        "bought",
        "deal",
        "offering",
        "immunovaccine",
        "inc",
        "entered",
        "bought",
        "deal",
        "financing",
        "agreement",
        "sell",
        "million",
        "common",
        "share",
        "price",
        "per",
        "common",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}